Skip to content
Accessibility
Accessibility
Higher contrast
Underline links
More readable font
Restore defaults
University portal
University of Veterinary Medicine and Pharmacy in Košice
Slovenčina
English
Sign in
Menu
Main menu
Home
Home
QUALITY SYSTEM
National Accreditation
ESEVT Evaluation
Internal quality system
UVLF Accreditation Commission decisions
Annual quality reports
Internal evaluation report
Annual assessments of study programmes
Cycle of the study programme
PDCA cycle
REGISTERS
Study fields
Study Programmes
Persons responsible for the quality of study programmes
Fields of habilitation and inauguration proceedings
Rigorous proceedings
PUBLICATIONS
PROJECTS
MAP
Search
Home
/
Profile
/
Research outputs
Research outputs
Assoc. prof. Takáč Peter, Pharm.D., PhD
Academic year: 2026/2027
Study programmes
Pharmacy
· I. + II. degree
full-time form
Publication year
Outputs
2022
V3 / ADC VILKOVÁ, Mária [15 %] - MICHALKOVÁ, Radka [15 %] - KELLO, Martin [15 %] - SABOLOVÁ, Danica [10 %] - TAKÁČ, Peter [10 %] - KUDLIČKOVÁ, Zuzana [10 %] - GARBEROVÁ, Monika [2 %] - TVRDOŇOVÁ, Monika [10 %] - BÉRES, Tibor [3 %] - MOJŽIŠ, Ján [10 %]. Discovery of novel acridine-chalcone hybrids with potent DNA binding and antiproliferative activity against MDA-MB-231 and MCF-7 cells. In Medicinal Chemistry Research. ISSN 1054-2523, 2022, vol. 31, no. 8, p. 1323-1338. (2022: 2.6 - IF, 2.3 - IF 5y, 56 - H-index, 0.377 - SJR, Q2 - SJR Best Q, Q3 - JCR Best Q). (2022 - Current Contents). Dostupné na internete: .
2021
ADC KUDLIČKOVÁ, Zuzana [40 %] - TAKÁČ, Peter [20 %] - SABOLOVÁ, Danica [20 %] - VILKOVÁ, Mária [5 %] - BALÁŽ, Matej [5 %] - BÉRES, Tibor [5 %] - MOJŽIŠ, Ján [5 %]. Novel 1-methoxyindole- and 2-alkoxyindole-based chalcones: design, synthesis, characterization, antiproliferative activity and DNA, BSA binding interactions. In Medicinal Chemistry Research. ISSN 1054-2523, 2021, vol. 30, no. 4, p. 897-912. (2021: 2.351 - IF, 2.261 - IF 5y, 50 - H-index, 0.357 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q). (2021 - Current Contents). Dostupné na internete: .
2018
ADC TAKÁČ, Peter [30 %] - KELLO, Martin [30 %] - BAGO PILÁTOVÁ, Martina [10 %] - KUDLIČKOVÁ, Zuzana [6 %] - VILKOVÁ, Mária [6 %] - SLEPČÍKOVÁ, Paulína [3 %] - PETIK, Peter [1 %] - MOJŽIŠ, Ján [14 %]. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In Chemico-Biological Interactions. ISSN 0009-2797, 2018, vol. 292, no., p. 37-49. (2018: 3.407 - IF, 3.299 - IF 5y, 115 - H-index, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q). (2018 - Current Contents).
2019
ADC ČIŽMÁRIKOVÁ, Martina [50 %] - TAKÁČ, Peter [25 %] - SPENGLER, Gabriela [10 %] - KINCSES, Annamária [5 %] - NOVÉ, Márta [2 %] - VILKOVÁ, Mária [3 %] - MOJŽIŠ, Ján [5 %]. New Chalcone derivative inhibits ABCB1 in multidrug resistant T-cell lymphoma and colon adenocarcinoma cells. In Anticancer Research. ISSN 0250-7005, 2019, vol. 39, no. 12, p. 6499-6505. (2019: 1.994 - IF, 1.931 - IF 5y, 117 - H-index, 0.716 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q). (2019 - Current Contents).
2023
V3 / ADC TAKÁČ, Peter [20 %] - MICHALKOVÁ, Radka [16 %] - ČIŽMÁRIKOVÁ, Martina [16 %] - BEDLOVIČOVÁ, Zdenka [16 %] - BALÁŽOVÁ, Ľudmila [16 %] - TAKÁČOVÁ, Gabriela [16 %]. The role of silver nanoparticles in the diagnosis and treatment of cancer: Are there any perspectives for the future? In Life. ISSN 2075-1729, 2023, vol. 13, no. 2, art. no. 466, p. [1-44]. (2022: 3.2 - IF, 3.2 - IF 5y, 46 - H-index, 0.634 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q). Dostupné na internete: .
Pharmacy (joint study programme)
· I. + II. degree
full-time form
Publication year
Outputs
2023
V3 / ADC TAKÁČ, Peter [20 %] - MICHALKOVÁ, Radka [16 %] - ČIŽMÁRIKOVÁ, Martina [16 %] - BEDLOVIČOVÁ, Zdenka [16 %] - BALÁŽOVÁ, Ľudmila [16 %] - TAKÁČOVÁ, Gabriela [16 %]. The role of silver nanoparticles in the diagnosis and treatment of cancer: Are there any perspectives for the future? In Life. ISSN 2075-1729, 2023, vol. 13, no. 2, art. no. 466, p. [1-44]. (2022: 3.2 - IF, 3.2 - IF 5y, 46 - H-index, 0.634 - SJR, Q2 - SJR Best Q, Q2 - JCR Best Q). Dostupné na internete: .
2019
ADC ČIŽMÁRIKOVÁ, Martina [50 %] - TAKÁČ, Peter [25 %] - SPENGLER, Gabriela [10 %] - KINCSES, Annamária [5 %] - NOVÉ, Márta [2 %] - VILKOVÁ, Mária [3 %] - MOJŽIŠ, Ján [5 %]. New Chalcone derivative inhibits ABCB1 in multidrug resistant T-cell lymphoma and colon adenocarcinoma cells. In Anticancer Research. ISSN 0250-7005, 2019, vol. 39, no. 12, p. 6499-6505. (2019: 1.994 - IF, 1.931 - IF 5y, 117 - H-index, 0.716 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q). (2019 - Current Contents).
2018
ADC TAKÁČ, Peter [30 %] - KELLO, Martin [30 %] - BAGO PILÁTOVÁ, Martina [10 %] - KUDLIČKOVÁ, Zuzana [6 %] - VILKOVÁ, Mária [6 %] - SLEPČÍKOVÁ, Paulína [3 %] - PETIK, Peter [1 %] - MOJŽIŠ, Ján [14 %]. New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway. In Chemico-Biological Interactions. ISSN 0009-2797, 2018, vol. 292, no., p. 37-49. (2018: 3.407 - IF, 3.299 - IF 5y, 115 - H-index, 0.923 - SJR, Q1 - SJR Best Q, Q2 - JCR Best Q). (2018 - Current Contents).
2021
ADC KUDLIČKOVÁ, Zuzana [40 %] - TAKÁČ, Peter [20 %] - SABOLOVÁ, Danica [20 %] - VILKOVÁ, Mária [5 %] - BALÁŽ, Matej [5 %] - BÉRES, Tibor [5 %] - MOJŽIŠ, Ján [5 %]. Novel 1-methoxyindole- and 2-alkoxyindole-based chalcones: design, synthesis, characterization, antiproliferative activity and DNA, BSA binding interactions. In Medicinal Chemistry Research. ISSN 1054-2523, 2021, vol. 30, no. 4, p. 897-912. (2021: 2.351 - IF, 2.261 - IF 5y, 50 - H-index, 0.357 - SJR, Q2 - SJR Best Q, Q4 - JCR Best Q). (2021 - Current Contents). Dostupné na internete: .
2022
V3 / ADC VILKOVÁ, Mária [15 %] - MICHALKOVÁ, Radka [15 %] - KELLO, Martin [15 %] - SABOLOVÁ, Danica [10 %] - TAKÁČ, Peter [10 %] - KUDLIČKOVÁ, Zuzana [10 %] - GARBEROVÁ, Monika [2 %] - TVRDOŇOVÁ, Monika [10 %] - BÉRES, Tibor [3 %] - MOJŽIŠ, Ján [10 %]. Discovery of novel acridine-chalcone hybrids with potent DNA binding and antiproliferative activity against MDA-MB-231 and MCF-7 cells. In Medicinal Chemistry Research. ISSN 1054-2523, 2022, vol. 31, no. 8, p. 1323-1338. (2022: 2.6 - IF, 2.3 - IF 5y, 56 - H-index, 0.377 - SJR, Q2 - SJR Best Q, Q3 - JCR Best Q). (2022 - Current Contents). Dostupné na internete: .
Back
Back to top